April 10, 2023
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
March 27, 2023
The NCI has awarded has awarded Shelley Earp, MD, and Yuliya Pylayeva-Gupta, PhD, a research project grant to investigate approaches to overcome barriers to pancreatic cancer immunotherapies.
October 7, 2022
UNC named UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, one of four recipients of the Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement.
October 6, 2022
UNC Lineberger researchers have found a possible way to overcome barriers that block anti-cancer immune responses. Their findings could have implications for treating solid tumors, including breast and pancreatic cancer.
October 3, 2022
The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.
May 6, 2022
UNC Lineberger’s 45th annual Scientific Symposium featured talks on the latest research on pancreatic cancer, tumor microenvironments, metastatic disease and immunotherapy.
January 11, 2022
Yuliya Pylayeva-Gupta, PhD, is a recipient of The Mark Foundation for Cancer Research Emerging Leader Award. The funding will support her research focused on reprogramming B cell fate and function in cancer.
November 9, 2020
Pancreatic cancer is an extremely challenging cancer to treat and has an increasing incidence in the United States. Fortunately, pancreatic cancer research is being conducted at UNC Lineberger.
September 23, 2019
The U.S. Army has awarded a $559,799 grant to UNC Lineberger Comprehensive Cancer Center researcher Yuliya Pylayeva-Gupta, PhD, to investigate the role of the immune system in promoting pancreatic cancer’s spread.
April 17, 2019
The National Cancer Institute has awarded a grant for more than $2.2 million across five years to UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, to support her research into the immune response in pancreatic cancer, one of the deadliest cancers.
